Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Demyelinating disease in SLE: Is it multiple sclerosis or lupus?
Viability of autoantibody-targets: How to tackle pathogenetic heterogeneity as an obstacle for treatment of multiple sclerosis.
Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models.
Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation.
ENCOMS: Argentinian survey in cost of illness and unmet needs in multiple sclerosis.
Catastrophic brain relapse in seronegative NMO after a single dose of natalizumab.
Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier.
Pre-existing T- and B-cell defects in one progressive multifocal leukoencephalopathy patient.
Postpartum complicated by transverse myelitis.
Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids.
Periventricular venous density in multiple sclerosis is inversely associated with T2 lesion count: a 7 Tesla MRI study.
Interferon-β1b Increases Th2 Response in Neuromyelitis Optica.
Fingolimod Phosphate Attenuates Oligomeric Amyloid β-Induced Neurotoxicity via Increased Brain-Derived Neurotrophic Factor Expression in Neurons.
Labour-associated increase in C-reactive protein concentration is not predictive of postpartum relapse activity among mothers with multiple sclerosis.
Detection of multiple sclerosis from exhaled breath using bilayers of polycyclic aromatic hydrocarbons and single-wall carbon nanotubes.
Headache and neurological disease in pregnancy.
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.
Telephone counseling and home telehealth monitoring to improve medication adherence: Results of a pilot trial among individuals with multiple sclerosis.
Treatment of Multiple Sclerosis With Chinese Scalp Acupuncture.
Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.
Melanoma complicating treatment with natalizumab for multiple sclerosis.
Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination.
Miscellaneous indications for extracorporeal photochemotherapy (ECP).
A combination trial of estriol plus glatiramer acetate in relapsing-remitting multiple sclerosis: effect on disabilities
The pathology of multiple sclerosis.
Pages
« first
‹ previous
…
196
197
198
199
200
201
202
203
204
…
next ›
last »